Adverum Biotechnologies Price Patterns
| ADVMDelisted Stock | USD 4.36 0.00 0.00% |
Momentum 44
Sell Extended
Oversold | Overbought |
Using Adverum Biotechnologies hype-based prediction, you can estimate the value of Adverum Biotechnologies from the perspective of Adverum Biotechnologies response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Adverum Biotechnologies to buy its stock at a price that has no basis in reality. In that case, they are not buying Adverum because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Adverum Biotechnologies after-hype prediction price | USD 4.36 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Adverum |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Adverum Biotechnologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Adverum Biotechnologies After-Hype Price Density Analysis
As far as predicting the price of Adverum Biotechnologies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Adverum Biotechnologies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Adverum Biotechnologies, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Adverum Biotechnologies Estimiated After-Hype Price Volatility
In the context of predicting Adverum Biotechnologies' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Adverum Biotechnologies' historical news coverage. Adverum Biotechnologies' after-hype downside and upside margins for the prediction period are 4.36 and 4.36, respectively. We have considered Adverum Biotechnologies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Adverum Biotechnologies is very steady at this time. Analysis and calculation of next after-hype price of Adverum Biotechnologies is based on 3 months time horizon.
Adverum Biotechnologies Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Adverum Biotechnologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Adverum Biotechnologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Adverum Biotechnologies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.36 | 4.36 | 0.00 |
|
Adverum Biotechnologies Hype Timeline
Adverum Biotechnologies is presently traded for 4.36. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Adverum is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on Adverum Biotechnologies is about 0.0%, with the expected price after the next announcement by competition of 4.36. About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.93. Some equities with similar Price to Book (P/B) outperform the market in the long run. Adverum Biotechnologies recorded a loss per share of 8.57. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 21st of March 2024. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.Adverum Biotechnologies Related Hype Analysis
Having access to credible news sources related to Adverum Biotechnologies' direct competition is more important than ever and may enhance your ability to predict Adverum Biotechnologies' future price movements. Getting to know how Adverum Biotechnologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Adverum Biotechnologies may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ARTV | Artiva Biotherapeutics Common | 0.00 | 0 per month | 7.65 | 0.04 | 8.00 | (11.11) | 118.69 | |
| GUTS | Fractyl Health Common | 0.00 | 0 per month | 3.68 | 0.14 | 11.89 | (5.49) | 31.63 | |
| STRO | Sutro Biopharma | 0.00 | 0 per month | 5.38 | 0.11 | 11.76 | (7.78) | 27.28 | |
| DTIL | Precision BioSciences | 0.00 | 0 per month | 0.00 | (0.28) | 4.71 | (8.82) | 15.28 | |
| MGX | Metagenomi Common Stock | 0.00 | 0 per month | 0.00 | (0.18) | 6.02 | (6.21) | 18.63 | |
| ALXO | Alx Oncology Holdings | 0.00 | 0 per month | 6.09 | 0.03 | 13.04 | (9.09) | 27.69 | |
| ATYR | aTyr Pharma | 0.00 | 0 per month | 3.67 | 0.01 | 7.79 | (6.10) | 22.83 | |
| BMEA | Biomea Fusion | 0.00 | 0 per month | 0.00 | (0.03) | 9.38 | (8.33) | 28.51 | |
| PLRX | Pliant Therapeutics | 0.00 | 0 per month | 0.00 | (0.14) | 4.58 | (6.71) | 22.72 | |
| QNCX | Quince Therapeutics | 0.00 | 0 per month | 4.40 | 0.17 | 11.88 | (7.90) | 42.36 |
Adverum Biotechnologies Additional Predictive Modules
Most predictive techniques to examine Adverum price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Adverum using various technical indicators. When you analyze Adverum charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Adverum Biotechnologies Predictive Indicators
The successful prediction of Adverum Biotechnologies stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Adverum Biotechnologies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Adverum Biotechnologies based on analysis of Adverum Biotechnologies hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Adverum Biotechnologies's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Adverum Biotechnologies's related companies.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Adverum Stock
If you are still planning to invest in Adverum Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adverum Biotechnologies' history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |